Why the study?
Do serum levels of sFas and sFasL at initial presentation predict the prognosis of acute myocarditis?
Do serum levels of sFas and sFasL at initial presentation predict the prognosis of acute myocarditis?
Elevated serum levels of sFas and sFasL at initial presentation are strong serological markers predicting fatal outcomes in patients with acute myocarditis.
No takes yet. Share an insight, caveat, or question.
Elevated sFas/sFasL associate with fatal acute myocarditis; hypothesis-generating for prognostic biomarkers pending validation.
Fuse et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: